Live from the NIH registry
Studies recruiting near Lincoln right now
Top 25 of 151 recruiting studies, sorted by proximity — each links to its official registry page
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum
N/A
Interventional 9,500 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: NRG Oncology
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Somnos Clinical Research — Lincoln, Nebraska (0.9 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Multi-Site Feasibility Testing of the Ventricular Assist Device Anticipatory Guidance Tool
Ventricular Assist Device, Advanced Heart Failure
N/A
Observational 10 participants sought
Bryan Heart — Lincoln, Nebraska (0.9 mi)
· Sponsor: Bryan Heart
A Phase 1 Study of BLKR201 in Healthy Adult Participants
Healthy
Phase 1
Interventional 128 participants sought
Celerion — Lincoln, Nebraska (0.9 mi)
· Sponsor: Formation Bio, Inc.
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer, c-MET
Phase 2
Interventional 150 participants sought
Nebraska Hematology-Oncology /ID# 272970 — Lincoln, Nebraska (0.9 mi)
· Sponsor: AbbVie
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Schizophrenia
N/A
Observational 1,500 participants sought
Alivation Research, LLC — Lincoln, Nebraska (0.9 mi)
· Sponsor: Bristol-Myers Squibb
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
Septic Shock, Sepsis
Phase 3
Interventional 46 participants sought
Bryan Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: Vivacelle Bio
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Solid Tumors
Phase 2
Interventional 750 participants sought
USA14-0 — Lincoln, Nebraska (0.9 mi)
· Sponsor: DualityBio Inc.
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Lincoln, Nebraska (0.9 mi)
· Sponsor: TG Therapeutics, Inc.
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
Atopic Dermatitis
N/A
Observational 1,000 participants sought
Allergy Asthma & Immunology- Site Number : 8400044 — Lincoln, Nebraska (0.9 mi)
· Sponsor: Sanofi
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
Saint Elizabeth Regional Medical Center — Lincoln, Nebraska (0.9 mi)
· Sponsor: National Cancer Institute (NCI)
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Solid Tumor, Adult
Phase 1, Phase 2
Interventional 348 participants sought
Nebraska Hematology Oncology — Lincoln, Nebraska (0.9 mi)
· Sponsor: Corbus Pharmaceuticals Inc.
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
End Stage Kidney Disease
Phase 2, Phase 3
Interventional 3,110 participants sought
GSR Enterprises, Inc. — Lincoln, Nebraska (0.9 mi)
· Sponsor: CSL Behring
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response
Major Depressive Disorder (MDD), Depressive Disorder, Treatment-Resistant
Phase 2
Interventional 153 participants sought
Alivation Research, LLC — Lincoln, Nebraska (0.9 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Nebraska Hematology and Oncology — Lincoln, Nebraska (0.9 mi)
· Sponsor: SWOG Cancer Research Network
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Diabetes Mellitus, Type 2, PreDiabetes
N/A
Interventional 7,500 participants sought
Bryan Heart — Lincoln, Nebraska (0.9 mi)
· Sponsor: Cleerly, Inc.
A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).
Healthy
Phase 1
Interventional 250 participants sought
Velocity Clinical Research Lincoln ( Site 0004) — Lincoln, Nebraska (0.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
Healthy Adult Male and Female Volunteers
Phase 1
Interventional 212 participants sought
Celerion — Lincoln, Nebraska (0.9 mi)
· Sponsor: Centessa Pharmaceuticals (UK) Limited
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
Alopecia Areata
Phase 3
Interventional 1,500 participants sought
Nebraska Dermatology /ID# 259354 — Lincoln, Nebraska (0.9 mi)
· Sponsor: AbbVie
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
Velocity Clinical Research-Lincoln-69943 — Lincoln, Nebraska (0.9 mi)
· Sponsor: Boehringer Ingelheim
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Aortic Stenosis, Coronary Artery Disease
N/A
Interventional 4,000 participants sought
Bryan Heart — Lincoln, Nebraska (0.9 mi)
· Sponsor: University of British Columbia
Assessment of CCM in HF With Higher Ejection Fraction
Heart Failure, Heart Failure With Preserved Ejection Fraction
N/A
Interventional 1,500 participants sought
Bryan Heart — Lincoln, Nebraska (0.9 mi)
· Sponsor: Impulse Dynamics
ACP-204 in Adults With Alzheimer's Disease Psychosis
Alzheimer's Disease Psychosis
Phase 2, Phase 3
Interventional 1,074 participants sought
Alivation Research, LLC — Lincoln, Nebraska (0.9 mi)
· Sponsor: ACADIA Pharmaceuticals Inc.
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 Diabetes, Cortisol Excess
Phase 2
Interventional 1,500 participants sought
Velocity Clinical Research, Lincoln — Lincoln, Nebraska (0.9 mi)
· Sponsor: Sparrow Pharmaceuticals